Nasal administration of the neuroprotective candidate NeuroEPO to healthy volunteers: A randomized, parallel, open-label safety study

Article

Abstract: Background: Delivery of therapeutic agents as erythropoietin (EPO) into Central Nervous System throu

Palabras claves:

Healthy volunteers, Hematopoietic activity, neurodegenerative diseases, NeuroEPO, Non-hematopoietic recombinant erythropoietin, safety, stroke

Autores:

Alfonso-Muñoz E., Amaro-González D., Carmen Elena Viada, Díaz-Machado A., Festary-Casanovas T., García-García I., González-Delgado C.A., Jiménez-Rodríguez D., Pérez-Rodríguez S., Piedra-Sierra P., Pomares-Iturralde Y., Santos-Morales O.

Fuentes:

scopus